Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction*
- 2 December 2004
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 19 (1) , 10-14
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypesCurrent Opinion in Nephrology and Hypertension, 2001
- The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosisAmerican Journal of Kidney Diseases, 2000
- Genetic Polymorphisms of the Renin-Angiotensin System and Atheromatous Renal Artery StenosisHypertension, 1999
- Lack of association of angiotensin-converting enzyme (Dd/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetesAmerican Journal of Kidney Diseases, 1999
- Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathyKidney International, 1998
- Plasminogen Activator Inhibitor-1 (PAI-1) Antigen Plasma Levels in Subjects Attending a Metabolic Ward: Relation to Polymorphisms of PAI-1 and Angiontensin Converting Enzyme (ACE) GenesArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Chronic transplant rejectionKidney International, 1994
- CHRONIC VASCULAR REJECTION OF THE HEART AND THE KIDNEY—HAVE RATIONAL TREATMENT OPTIONS EMERGED?Transplantation, 1992
- CHRONIC REJECTION—AN UNDEFINED CONUNDRUMTransplantation, 1991
- Histopathologic findings associated with a chronic, progressive decline in renal allograft functionKidney International, 1991